Medication info
Amplin 10 mg (Empagliflozin)

Amplin 10 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Light yellow, double convex, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102580 · Approved 2021.03.24 · Insurance code 653405970

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine for monotherapy and add-on combination therapy with other blood glucose-lowering agents such as insulin is 10 mg once daily. If additional glycemic control is needed and 10 mg of this medicine is well tolerated, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be administered with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take twice the dose in one day. Special Populations •Patients with renal impairment No dosage adjustment is required in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with a glomerular filtration rate (eGFR) less than 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently glomerular filtration rate less than 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medicine should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to less than 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in these patients. •Elderly patients No dosage adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age or older. Initiation of treatment with this medicine is not recommended in elderly patients 85 years of age or older because clinical experience is limited (see Precautions for Use, 4. General Precautions)

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty controlling blood sugar
  • cardiovascular disease
View approved original text

This medication is used alongside dietary and exercise therapy to help control blood sugar levels in adults with type 2 diabetes. It can be used alone or in combination with other diabetes medications such as Metformin, Pioglitazone, Sulfonylureas, Insulin, DPP-4 inhibitors for patients who have difficulty controlling their blood sugar or are already taking other diabetes medications. It is particularly effective in patients whose blood sugar is poorly controlled, and special care is required for patients with concomitant cardiovascular disease. This medication effectively improves blood glucose levels and aids in diabetes treatment.

How to take

Adult dose

The recommended dose of this medicine for monotherapy and add-on combination therapy with other blood glucose-lowering agents such as insulin is 10 mg once daily. If additional glycemic control is needed and 10 mg of this medicine is well tolerated, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be administered with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take twice the dose in one day. Special Populations •Patients with renal impairment No dosage adjustment is required in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with a glomerular filtration rate (eGFR) less than 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently glomerular filtration rate less than 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medicine should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to less than 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in these patients. •Elderly patients No dosage adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age or older. Initiation of treatment with this medicine is not recommended in elderly patients 85 years of age or older because clinical experience is limited (see Precautions for Use, 4. General Precautions)

Precautions

This medication should not be administered to certain patients. Firstly, patients who are allergic to the active ingredient or any component of this medication should not take it. Secondly, it should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Thirdly, it is not administered to patients with severely impaired kidney function or end-stage renal disease, and those undergoing dialysis. Fourthly, since it contains lactose, patients with lactose intolerance or galactose intolerance, as well as those with glucose-galactose malabsorption syndrome should not take this medication. Caution is required when administering this medication to patients with decreased kidney function. If kidney function falls below a certain level, dosage adjustments may be necessary or treatment may need to be stopped. It is not used in patients with end-stage renal disease or those on dialysis as its effectiveness cannot be expected. Regular monitoring of kidney function is essential to observe any changes. In patients with mild to moderate heart failure, caution is advised, and it is not recommended for patients with severe heart failure. There is a risk of hypoglycemia when used in conjunction with insulin or medications that promote insulin secretion, and dosage adjustments of insulin may be necessary when used with these medications. Various adverse reactions may occur during the use of this medication. The most common adverse reactions include hypoglycemia, genital infections, urinary tract infections, increased urination, and decreased fluid volume. Particularly, hypoglycemia can occur more frequently when combined with insulin or sulfonylureas. Additionally, severe metabolic acidosis such as ketoacidosis can rarely occur, in which case treatment should be stopped immediately, and evaluation and treatment by medical personnel are required. This medication is not used for the treatment of type 1 diabetes. Elderly patients, especially those over 75 years of age, are at a higher risk for fluid volume loss complications such as dehydration or hypotension and require caution. This medication may increase the risk of genital fungal infections, so patients with a history of fungal infections should be particularly cautious. Caution is advised when driving or operating machinery due to the risk of hypoglycemia. Particularly, if used in conjunction with insulin or sulfonylureas, extra care should be taken. Women who are pregnant or planning to become pregnant should not take this medication, and treatment should be stopped immediately upon confirmation of pregnancy. It is also recommended for breastfeeding women to stop breastfeeding while taking this medication. The safety and efficacy of this medication in patients who are children or adolescents, specifically those under 18 years of age, have not been established, and it should not be used in this population. In cases of overdose, no specific toxicity symptoms have been reported; however, appropriate treatment should be provided based on clinical condition. This medication should be kept out of reach of children, and transferring it to other containers should be avoided to maintain quality and safety.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • pruritus
  • rash
  • urticaria
Show 234 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ureteral stones
  • acute kidney injury
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • headache
  • positional dizziness
  • sensory loss
  • perceptual abnormalities
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory impairments
  • neuralgia
  • Parkinson's disease
  • polyneuropathy
  • sensory disorders
  • drowsiness
  • central nervous system-origin vertigo
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • fever
  • facial swelling
  • chills
  • strange sensations
  • swelling
  • pain
  • tenderness at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • chest pain
  • fatigue
  • peripheral swelling
  • facial swelling
  • swelling
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • Helicobacter test positive
  • urine positive for red blood cells
  • ureteral stones
  • hematuria
  • renal mass
  • urinary retention
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical inflammation
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • hyperglycemia
  • diabetes
  • hyperlipidemia
  • hyponatremia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spine stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • low back pain
  • limb pain
  • musculoskeletal chest pain
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • glaucoma
  • macular fibrosis
  • eye discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • preocular retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual sputum
  • cough
  • epistaxis
  • allergic rhinitis
  • limb injuries
  • skin lacerations
  • contusions
  • rib fractures
  • concussion
  • corneal abrasion
  • falls
  • hand fractures
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal's angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • unstable angina
  • upper abdominal pain
  • dental caries
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • ischemic colitis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • bloody stool
  • hemorrhoids
  • gastrointestinal bleeding
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • herpes zoster
  • positional dizziness
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • anxiety
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be kept in a tightly closed container. It is best stored at room temperature between 1 and 30 degrees Celsius. This will help maintain its effectiveness safely.

Appearance and packaging

Appearance

Light yellow, double convex, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.